Editorial Commentary
The added value of a deep learning-based computer-aided detection system on prostate cancer detection among readers with varying level of multiparametric MRI expertise
Chinese Clinical Oncology
2022;
11
(6)
:42
.
(31 December 2022)
Original Article
A prospective cohort study of TIMP1 as prognostic biomarker in gastric and colon cancer
Chinese Clinical Oncology
2022;
11
(6)
:43
.
(31 December 2022)
High local control and low ocular toxicity using ultra-low-dose “boom-boom” radiotherapy for indolent orbital lymphoma
Chinese Clinical Oncology
2022;
11
(6)
:44
.
(31 December 2022)
Review Article
A patient-centered, multidisciplinary approach to treating borderline resectable pancreatic adenocarcinoma
Chinese Clinical Oncology
2022;
11
(6)
:45
.
(31 December 2022)
Proton radiotherapy for glioma and glioblastoma
Chinese Clinical Oncology
2022;
11
(6)
:46
.
(31 December 2022)
Palliative interventions for patients with advanced gastric cancer: a systematic review
Chinese Clinical Oncology
2022;
11
(6)
:47
.
(31 December 2022)
Editorial Commentary
GEMSTONE-302: “If you keep doing the same thing you get the same result”
Chinese Clinical Oncology
2022;
11
(6)
:48
.
(31 December 2022)
The role of traditional, complementary, and alternative medicine in cancer care in the Philippines
Chinese Clinical Oncology
2022;
11
(6)
:49
.
(31 December 2022)
Interviews with Outstanding Guest Editors1
Interview with prof. Ghassan K. Abou-Alfa: gallbladder interview—a lone forgotten disease under the microscope
Chinese Clinical Oncology
2022;
11
(6)
:50
.
(31 December 2022)
Interview with Prof. Chérif Akladios: Sentinel lymph node in gynaecologic malignancy, the beginning of a new area in lymph node surgery
Chinese Clinical Oncology
2022;
11
(6)
:51
.
(31 December 2022)
Disclosure:
1. The series “Interviews with Outstanding Guest Editors” was commissioned by the editorial office, Chinese Clinical Oncology without any funding or sponsorship.